Because of its prominent role in the HSR, HSP90 is another promising drug target for cancer treatment, with multiple drugs and compounds shown to decrease cancer cell proliferation that moved into clinical trials (34, 92, 173). The gene discussed is HSP90AA1; the disease is cancer.